NWBS Northw.Bio Regs

    RNS Number : 2471A
  Northwest Biotherapeutics Inc
  30 July 2008
   



 For Immediate Release  30 July 2008

            

    Northwest Biotherapeutics
    ("NWBT" or the "Company")


    Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announced it has issued 146,768 shares of common stock $0.001 par
value, representing 0.3466% of the issued share capital. The shares were issued in fulfillment of a US$ 225,000 consideration for an option
to acquire certain assets of MithraGen Corporation and in fulfillment of the exercise of certain employee stock options.   The shares were
issued as follows: 754 shares on 17 April 2008 at a price of $2.267 per share; 122,190 shares on 17 June 2008 at $1.8414 per share and
23,824 shares on 27 June 2008 at $0.60 per share. 

    Application has been made today for the shares to be admitted to trading on AIM on 5 August 2008.


    For further information, please contact:

 Northwest Biotherapeutics
 Anthony P. Deasey, Chief Financial Officer                    +1 240-497-9024




 Buchanan Communications
 Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane         +44 (0)20 7466 5000
 Johnson / Catherine Breen 

 Collins Stewart
 Adam Cowen/Tim Mickley                                    +44 (0)20 7523 8230



This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
MSCFKKKDPBKDOON

Northw.Bio Regs (LSE:NWBS)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Northw.Bio Regs (LSE:NWBS)
Historical Stock Chart
Von Jun 2023 bis Jun 2024